James M Frates Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity
James M Frates is Chief Financial Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 225,964 shares of AMLX, which is worth approximately $388,658. The most recent transaction as insider was on Apr 16, 2024, when has been sold 91,180 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
226K
67.65%
3M change
305.86%
12M change
Total Value Held
$388,658
JAMES M FRATES Transaction History
Also insider at
JMF
James M Frates
Chief Financial Officer
Cambridge, MA